SARS-CoV-2 infections in households in a peri-urban community of Lima, Peru: A prospective cohort study

Influenza Other Respir Viruses. 2022 May;16(3):386-394. doi: 10.1111/irv.12952. Epub 2021 Dec 27.

Abstract

Background: We assessed the prevalence and incidence of SARS-CoV-2 infections in a prospective study of households in Lima, Peru.

Methods: Households with a child, a young adult 18-50 years, and an adult age >50 years in peri-urban Lima were followed with twice-a-week household visits during a 2-month period. Nasal swabs and saliva specimens were collected twice weekly, and nasopharyngeal swabs were collected weekly from each participant, regardless of symptoms. Laboratory-confirmed SARS-CoV-2 infection was defined by two RT-PCR tests from any of the collected specimens within a week. Blood samples collected at enrollment and end of follow-up were tested with rapid serological tests. We calculated the prevalence and incidence of laboratory-confirmed SARS-CoV-2 infections.

Results: We enrolled 132 participants from 44 households: 44 children, 44 young adults, and 44 older adults. A total of 13 SARS-CoV-2 infections were detected in eight households, for an overall period prevalence of 9.85% (95% confidence interval [CI]: 5.35-16.25). Most (61.54%) infections were symptomatic. Eight of 11 (72.73%) SARS-CoV-2 detections corresponded to the Lambda variant. During 218.79 person-months at risk of follow-up, there were six new SARS-CoV-2 infections detected (2.74 per 100 person-month, 95% CI: 1.25-6.04). At enrollment, 59 of 128 participants tested had positive SARS-CoV-2 IgG serology (46.09%, 95% CI: 37.25-55.12). Five of six new infections occurred among participants with negative baseline serology.

Conclusions: We demonstrated high incidence of SARS-CoV-2 infections in households, especially among subjects without evidence of prior infection, most of them not detected by the Ministry of Health system.

Keywords: COVID-19; Peru; SARS-CoV-2; cohort; incidence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • COVID-19* / diagnosis
  • COVID-19* / epidemiology
  • Child
  • Humans
  • Middle Aged
  • Peru / epidemiology
  • Prospective Studies
  • SARS-CoV-2
  • Young Adult

Supplementary concepts

  • SARS-CoV-2 variants